Gian Life Care opened at ₹4.32, in line with its previous close of ₹4.32. In the last trading session on 12 Nov 2026, the stock traded between ₹4.12 and ₹4.37, with an average traded price of ₹4.32. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of ₹10,000 made 5 years ago in Gian Life Care is now worth
₹ 960.00
Resulting in a loss of
₹ 9,040.00 (90.40%)
Invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+0.00 (+0.00%)
Day High
₹4.37
Day Low
₹4.12
Day Open
₹4.32
Prev Close
₹4.32
Volume
543
Value Traded
₹0.00 Cr
1W Return
1.65%
1M Return
0.93%
3M Return
-12.20%
6M Return
-27.88%
1Y Return
-66.72%
Fundamentals
Market Cap (₹ Cr.)
5
PE Ratio
-4.70
PB Ratio
0.24
Dividend Yield
-
ROE
-0.19%
ROCE
2.36%
Book Value (₹)
18.15
Face Value (₹)
10.00
EPS (TTM)
0.10
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
1.65%
6 Weeks
-
1 Month
0.93%
3 Months
-12.20%
9 Months
-56.14%
Financials
Yearly
Consolidated
All values in ₹ crores
0.16
Mar 22
0.13
Mar 23
0.14
Mar 24
0.07
Mar 25
Share Holding Pattern
Promoter30.17%
FII0.00%
DII0.00%
Retails & Others53.47%
Updates
4Mar
Gian Life Care Limited Enters Strategic Partnership with Brahma Hospital for Lab Management Services
Gian Life Care Limited has entered into a 5-year strategic partnership with M/s. Brahma Hospital (HUF) for hospital lab management services in Roorkee, Uttarakhand, effective March 01, 2026. The collaboration is expected to generate approximately INR 1 crore in additional annual revenue and increase net profit by INR 18-20 lakhs annually. The partnership aims to strengthen the company's market position in diagnostic and healthcare services in the region, representing a significant expansion opportunity in the Uttarakhand healthcare market.
8mo ago
14Feb
Gian Life Care Limited Reports Q3FY26 Results with Auditor Concerns Over Cash Balance
Gian Life Care Limited announced Q3FY26 results showing recovery with standalone revenue of ₹112.28 lakhs and net profit of ₹12.03 lakhs, bouncing back from Q2FY26 loss of ₹46.58 lakhs. However, auditors MSNT & Associates LLP raised significant concerns about the company's reported cash balance of ₹743.78 lakhs while substantial obligations including statutory dues of ₹426.66 lakhs and NPA bank loan of ₹359.78 lakhs remain unpaid, questioning financial transparency.
9mo ago
28Jan
Gian Life Care Reports Q2FY26 Loss of ₹46.20 Lakhs Amid Revenue Decline
Gian Life Care Limited reported a net loss of ₹46.20 lakhs for Q2FY26 versus profit of ₹14.19 lakhs in Q2FY25, with revenue declining 66.09% to ₹66.00 lakhs. The company faces operational challenges with total expenses at ₹125.04 lakhs and loss before tax of ₹49.72 lakhs. Auditors raised concerns about cash balance verification, noting ₹743.78 lakhs in cash while ₹426.66 lakhs in statutory dues and ₹359.78 lakhs in NPA bank loans remain unpaid.
